Infective Endocarditis due to Achromobacter Xylosoxidans
Journal: International Journal of Science and Research (IJSR) (Vol.9, No. 9)Publication Date: 2020-09-05
Authors : Amandeep Singh Rawat; Jyoti Kathait; Manisha Bhandari;
Page : 613-616
Keywords : Achromobacter xylosoxidans; Endocarditis; immunocompromised; modified Duke Criteria;
Abstract
Achromobacter xylosoxidans was first described by Yabuuchi and Ohyama in 1971 from purulent ear discharge of patients with chronic, inflammatory otitis media. Endocarditis due to Achromobacter xylosoxidans species is a very rare yet serious, endovascular infection. Affected individuals are usually immunocompromised, but nosocomial outbreaks have also been defined. It has a near-fatal outcome without surgical intervention. The clinical presentation of IE is highly variable which makes its diagnosis very difficult. The diagnosis of infectious endocarditis requires multiple clinical (modified Duke Criteria), laboratory (microbiological), and imaging findings (CT scan, MRI etc. ). The treatment of infections caused by this organism is difficult due to the lack of a standard therapy and resistance to several antibiotics.
Other Latest Articles
- STEMCELL: An Instrument to Improve Outcomes of Islet Transplantation
- Stubble Burning in Punjab: Problems and Issues
- The Role of Personal Worries and Trust in Authorities in Explaining Risk Perception among Students from the University
- Customer Satisfaction Survey of Implemented Energy Efficiency Measures in Public Buildings in Kosovo
- Buddhism: A Religion of Practice
Last modified: 2021-06-28 17:11:32